
Globalization
Key Insights for Policymakers: Chinas Impact on US Drug Supply Chains and Strategic Responses
China faces concerns over potential disruptions to the U.S. drug supply chain, driving decoupling measures and support for domestic production. It is vital to prioritize the most relevant chains and develop a comprehensive strategy that includes reviewing critical medicines and their vulnerability, as well as funding availability and political commitment.
